Cryoport, Inc. (NASDAQ:CYRX) Q2 2023 Earnings Conference Call August 9, 2023 5:00 PM ET

Corporate Participants

Todd Fromer - Investor Relations, KCSA Strategic Communications

Jerrell Shelton - Chief Executive Officer

Robert Stefanovich - Chief Financial Officer

Mark Sawicki - Chief Scientific Officer

Thomas Heinzen - Vice President, Corporate Development and Investor Relations

Conference Call Participants

Puneet Souda - SVB Securities

David Saxon - Needham & Company

Lucas Beaumont - UBS

David Larsen - BTIG

Yuan Zhi - B. Riley

Richard Baldry - ROTH MKM

Brandon Couillard - Jefferies

Operator

Good afternoon, ladies and gentlemen, and welcome to the Cryoport Second Quarter 2023 Earnings Conference Call. At this time, all lines are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator Instructions] As a reminder, this call is being recorded.

I would now turn the call over to your host, Mr. Todd Fromer from KCSA Strategic Communications. Please go ahead.

Todd Fromer

Thank you, operator.

Before we begin today, I would like to remind everyone that this conference call contains certain forward-looking statements. All statements that address our operating performance, events or developments that we expect or anticipate occurring in the future are forward-looking statements. These forward-looking statements are based on management’s beliefs and assumptions and not on information currently available to our management team.

Our management team believe that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information or future events or otherwise accept as required by law.

In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in Item 1A, Risk Factors and elsewhere in our annual report on Form 10-K filed with the Securities and Exchange Commission and those described from time-to-time in other reports which we file with the Securities and Exchange Commission.

It is now my pleasure to turn the call over to Mr. Jerrell Shelton, Chief Executive Officer of Cryoport. Jerry, the floor is yours.

Jerrell Shelton

Thank you, Todd. Good afternoon, ladies and gentlemen. We appreciate your joining earnings call today. With us this afternoon is our Chief Financial Officer, Robert Stefanovich, our Chief Scientific Officer, Dr. Marks Sawicki, and our Vice President of Corporate Development and Investor Relations, Thomas Heinzen.